What happened to asensus surgical?

It also represents a premium of approximately 52% to the closing price on the last trading day prior to the date of this announcement. After the transaction closes, Asensus Surgical will become a subsidiary of KARL STORZ Endoscopy-America. It will no longer be publicly listed or traded on the NYSE American Exchange.

Who owns asensus Surgical Inc & Karl Storz endoscopy-America?

Asensus Surgical Inc. ASXC gets into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a wholly owned subsidiary of KARL STORZ SE & Co. KG. The merger agreement states that KARL STORZ will acquire all of the outstanding shares of Asensus Surgical for 35 cents per share in cash.

How will asensus surgical's merger impact stockholder value?

The merger is expected to maximize Asensus Surgical’s stockholder value. With this transaction, Asensus will have a greater opportunity to advance in safer, predictable surgery and digital tools for patients and surgeons all over the world.